TruAlt Bioenergy Limited — PPTs, 28-07-2026: Investor Presentation

Here's a summary of TruAlt Bioenergy's Q1 FY27 performance, tailored for retail investors:

**Business Performance:**

TruAlt Bioenergy saw substantial growth in its Q1 FY27 results. Total income surged by ~99% QoQ to ₹630.37 Cr. The company's strategic shift to a dual-feed ethanol platform, utilizing both sugar and grain-based feedstocks, has boosted profitability and enabled near year-round production. This diversification led to a significant jump in EBITDA by over 260% QoQ to ₹126.61 Cr.

**Growth Drivers or Strategy:**

The company is focused on expanding its bioenergy footprint. Key initiatives include advancing its 100 million litre/annum Sustainable Aviation Fuel (SAF) project and constructing additional Compressed Biogas (CBG) plants in partnership with Sumitomo Corporation and GAIL. The development of a retail fuel network is also progressing in a disciplined manner.

**Recent Developments:**

TruAlt has successfully integrated approximately 1,300 KLPD of dual-feed infrastructure into its ethanol capacity, transforming its production capabilities. Preparatory activities for six additional CBG plants are underway.

**Key Financial Metrics:**

* **Total Income:** ₹630.37 Cr. (vs ₹316.49 Cr. in Q1 FY26)

* **EBITDA:** ₹126.61 Cr. (vs ₹34.89 Cr. in Q1 FY26)

* **Profit After Tax (PAT):** ₹55.01 Cr. (vs ₹0.03 Cr. in Q1 FY26)

**Management Commentary / Outlook:**

Management is optimistic about India's bioenergy future, citing strong policy support and technological advancements. TruAlt is committed to disciplined execution and operational excellence to build an integrated clean energy platform across ethanol, CBG, SAF, and fuel retailing, aiming to create enduring value for stakeholders.